Osteogenesis in human periodontal ligament stem cell sheets is enhanced by the protease-activated receptor 1 (PAR1) in vivo

被引:0
|
作者
Tomaz Alves
Letícia M. Gasparoni
Danilo Balzarini
Emmanuel Albuquerque-Souza
Victhor de Oliveira
Emanuel S. Rovai
Jose da Silva
Aldrin Huamán-Mendoza
Luiz H. Catalani
Carla R. Sipert
Marinella Holzhausen
机构
[1] University of North Carolina,Division of Comprehensive Oral Health, Adams School of Dentistry
[2] University of São Paulo,Division of Periodontology, Department of Stomatology, School of Dentistry
[3] University of Pennsylvania,Department of Periodontics, School of Dental Medicine
[4] University of São Paulo,Division of Anatomy, Institute of Biomedical Sciences
[5] University of Taubate,Division of Periodontology, Dental School
[6] University of São Paulo,Department of Fundamental Chemistry, Institute of Chemistry
[7] University of São Paulo,Division of Endodontics, Department of Dentistry, School of Dentistry
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Human periodontal ligament stem cells (PDLSCs) have been studied as a promising strategy in regenerative approaches. The protease-activated receptor 1 (PAR1) plays a key role in osteogenesis and has been shown to induce osteogenesis and increase bone formation in PDLSCs. However, little is known about its effects when activated in PDLSCs as a cell sheet construct and how it would impact bone formation as a graft in vivo. Here, PDLSCs were obtained from 3 patients. Groups were divided into control, osteogenic medium and osteogenic medium + PAR1 activation by TFLLR-NH2 peptide. Cell phenotype was determined by flow cytometry and immunofluorescence. Calcium deposition was quantified by Alizarin Red Staining. Cell sheet microstructure was analyzed through light, scanning electron microscopy and histology and transplanted to Balb/c nude mice. Immunohistochemistry for bone sialoprotein (BSP), integrin β1 and collagen type 1 and histological stains (H&E, Van Giesson, Masson’s Trichrome and Von Kossa) were performed on the ex-vivo mineralized tissue after 60 days of implantation in vivo. Ectopic bone formation was evaluated through micro-CT. PAR1 activation increased calcium deposition in vitro as well as BSP, collagen type 1 and integrin β1 protein expression and higher ectopic bone formation (micro-CT) in vivo.
引用
收藏
相关论文
共 50 条
  • [21] PROTEASE-ACTIVATED RECEPTOR 1 (PAR1) MEDIATES ANTI-INFLAMMATORY EFFECTS IN A MOUSE MODEL OF PROSTATITIS
    Stanton, M. M.
    Nelson, L. K.
    Hollenberg, M. D.
    Buret, A. G.
    Ceri, H.
    INFLAMMATION RESEARCH, 2011, 60 : 247 - 248
  • [22] Monocyte activation via protease-activated receptor 1 (PAR1) leads to an upregulation of molecules involved in fibrinolysis
    Thaler, B.
    Hohensinner, P.
    Baumgartner, J.
    Schoergenhofer, C.
    Fischer, M.
    Jilma, B.
    Speidl, W.
    Wojta, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S88 - S88
  • [23] Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal Cancer Prognosis
    Yoshinori Fujita
    Yujiro Fukuda
    Fumiaki Sanuki
    Isao Irei
    Yasumasa Monobe
    Masako Uno
    Takeshi Akisada
    Koichiro Shimoya
    Hirotaka Hara
    Takuya Moriya
    Head and Neck Pathology, 2023, 17 : 658 - 672
  • [24] Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal Cancer Prognosis
    Fujita, Yoshinori
    Fukuda, Yujiro
    Sanuki, Fumiaki
    Irei, Isao
    Monobe, Yasumasa
    Uno, Masako
    Akisada, Takeshi
    Shimoya, Koichiro
    Hara, Hirotaka
    Moriya, Takuya
    HEAD & NECK PATHOLOGY, 2023, 17 (03): : 658 - 672
  • [25] Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias
    Veiga, Camilla de S. B.
    Carneiro-Lobo, Tatiana C.
    Coelho, Claudia J. B. P.
    Carvalho, Silvia M. F.
    Maia, Raquel C.
    Vasconcelos, Flavia C.
    Abdelhay, Eliana
    Mencalha, Andre L.
    Ferreira, Aline F.
    Castro, Fabiola A.
    Monteiro, Robson Q.
    BLOOD CELLS MOLECULES AND DISEASES, 2011, 46 (03) : 230 - 234
  • [26] Thrombin-induced slowly inactivating sodium current by protease-activated receptor PAR1 activation in human cardiomyocytes
    Pinet, C
    Coulombe, A
    Le Grand, B
    Perez, M
    John, G
    EUROPEAN HEART JOURNAL, 2003, 24 : 508 - 508
  • [27] Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia
    Schoergenhofer, Christian
    Schwameis, Michael
    Gelbenegger, Georg
    Buchtele, Nina
    Thaler, Barbara
    Mussbacher, Marion
    Schabbauer, Gernot
    Wojta, Johann
    Jilma-Stohlawetz, Petra
    Jilma, Bernd
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (07) : 1176 - 1184
  • [28] Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter
    Huang, Shih-Che
    REGULATORY PEPTIDES, 2007, 142 (1-2) : 37 - 43
  • [29] Thrombin and its protease-activated receptor-1 (PAR1) participate in the endothelial-mesenchymal transdifferentiation process
    Arciniegas, E
    Neves, CY
    Candelle, D
    Cardier, JE
    DNA AND CELL BIOLOGY, 2004, 23 (12) : 815 - 825
  • [30] Paradigm of Biased PAR1 (Protease-Activated Receptor-1) Activation and Inhibition in Endothelial Cells Dissected by Phosphoproteomics
    van den Eshof, Bart L.
    Hoogendijk, Arie J.
    Simpson, Pelle J.
    van Alphen, Floris P. J.
    Zanivan, Sara
    Mertens, Koen
    Meijer, Alexander B.
    van den Biggelaar, Maartje
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (10) : 1891 - +